We & Win Diversification Co., Ltd.

Taipei Exchange 4113.TWO

We & Win Diversification Co., Ltd. Price to Earnings Ratio (P/E) on January 14, 2025: -39.08

We & Win Diversification Co., Ltd. Price to Earnings Ratio (P/E) is -39.08 on January 14, 2025, a 51.54% change year over year. Price to earnings ratio compares the stock price to earnings per share; higher P/E suggests expectations for future earnings growth.
  • We & Win Diversification Co., Ltd. 52-week high Price to Earnings Ratio (P/E) is -39.08 on January 14, 2025, which is 0.00% below the current Price to Earnings Ratio (P/E).
  • We & Win Diversification Co., Ltd. 52-week low Price to Earnings Ratio (P/E) is -82.54 on August 01, 2024, which is -111.23% below the current Price to Earnings Ratio (P/E).
  • We & Win Diversification Co., Ltd. average Price to Earnings Ratio (P/E) for the last 52 weeks is -53.44.
Key data
Date Price to Earnings Ratio (P/E) Price to Sales Ratio (P/S) Price to Book Ratio (P/B) Dividend Yield
Market news
Loading...
Taipei Exchange: 4113.TWO

We & Win Diversification Co., Ltd.

CEO Mr. Yung-Yi Su
IPO Date Dec. 31, 2007
Location
Headquarters No. 185, Fuguo Road
Employees 35
Sector Consumer Staples
Industries
Description

We & Win Diversification Co., Ltd. engages in the rental and sale of real estate properties in Taiwan. It is also involved in the public construction investment; new towns and community development; wholesale of medical equipment; and international trade businesses. The company was formerly known as Oncoprobe Biotech Inc. and changed its name to We & Win Diversification Co., Ltd. in 2009. We & Win Diversification Co., Ltd. was founded in 1987 and is based in Kaohsiung City, Taiwan.

StockViz Staff

January 15, 2025

Any question? Send us an email